Jerry Gurwitz to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications Jerry Gurwitz has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
0.742
-
Gurwitz JH, Magid DJ, Smith DH, Tabada GH, Sung SH, Allen LA, McManus DD, Goldberg RJ, Tisminetzky M, Go AS. Treatment Effectiveness in Heart Failure with Comorbidity: Lung Disease and Kidney Disease. J Am Geriatr Soc. 2017 Dec; 65(12):2610-2618.
Score: 0.543
-
Doubeni C, Bigelow C, Lessard D, Spencer F, Yarzebski J, Gore J, Gurwitz J, Goldberg R. Trends and outcomes associated with angiotensin-converting enzyme inhibitors. Am J Med. 2006 Jul; 119(7):616.e9-16.
Score: 0.063
-
Rochon PA, Sykora K, Bronskill SE, Mamdani M, Anderson GM, Gurwitz JH, Gill S, Tu JV, Laupacis A. Use of angiotensin-converting enzyme inhibitor therapy and dose-related outcomes in older adults with new heart failure in the community. J Gen Intern Med. 2004 Jun; 19(6):676-83.
Score: 0.054
-
Tisminetzky M, Gurwitz JH, Tabada G, Reynolds K, Fortmann SP, Garcia E, Pham T, Goldberg R, Go AS. Adverse Events After Initiating Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Therapy in Individuals with Heart Failure and Multimorbidity. Am J Med. 2022 12; 135(12):1468-1477.
Score: 0.048
-
Steinman MA, Handler SM, Gurwitz JH, Schiff GD, Covinsky KE. Beyond the prescription: medication monitoring and adverse drug events in older adults. J Am Geriatr Soc. 2011 Aug; 59(8):1513-20.
Score: 0.022
-
Harrold LR, Lessard D, Yarzebski J, Gurwitz JH, Gore JM, Goldberg RJ. Age and sex differences in the treatment of patients with initial acute myocardial infarction: a community-wide perspective. Cardiology. 2003; 99(1):39-46.
Score: 0.012